6533b831fe1ef96bd1299a77

RESEARCH PRODUCT

Evaluation Of Alloimmune Responses In Humanized NOD/SCID/IL2rgnull Mice Following Human CD34+ Stem Cell Transplantation

Ralf G. MeyerJulia HemmerlingJ. HoffmannUdo F. HartwigChristoph HuberM.c. AndreRupert HandgretingerWolfgang Herr

subject

TransplantationTransplantationbusiness.industryImmunologyCD34MedicineHematologyNodStem cellbusinesshttps://doi.org/10.1016/j.bbmt.2008.12.397